Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Israel Journal of Chemistry

• Publication date

  2010-08-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/IJCH.201000016PMID 21331318PMCID PMC3038583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.

  2010cited by this paper
• Stability and Biodistribution of a Biodegradable Macromolecular MRI Contrast Agent Gd-DTPA Cystamine Copolymers (GDCC) in Rats

  2010cited by this paper
• Application of a biodegradable macromolecular contrast agent in dynamic contrast‐enhanced MRI for assessing the efficacy of indocyanine green‐enhanced photothermal cancer therapy

  2009cited by this paper
• Tumor Characterization with Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice

  2009cited by this paper
• Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.

  2009cited by this paper
• Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

  2008cited by this paper
• Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.

  2008cited by this paper
• Modification of Gd‐DTPA cystine copolymers with PEG‐1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography

  2007cited by this paper
• Gd-DTPA l-Cystine Bisamide Copolymers as Novel Biodegradable Macromolecular Contrast Agents for MR Blood Pool Imaging

  2006cited by this paper
• Macromolecular MRI contrast agents for imaging tumor angiogenesis.

  2006cited by this paper
• Pharmacokinetics, Biodistribution and Contrast Enhanced MR Blood Pool Imaging of Gd-DTPA Cystine Copolymers and Gd-DTPA Cystine Diethyl Ester Copolymers in a Rat Model

  2006cited by this paper
• PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.

  2005cited by this paper
• The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.

  2005cited by this paper
• Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.

  2005cited by this paper
• Nano-sized MRI contrast agents with dendrimer cores.

  2005cited by this paper
• Pharmacokinetics and Tissue Retention of (Gd-DTPA)-Cystamine Copolymers, a Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agent

  2005cited by this paper
• Contrast‐enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor‐bearing mice

  2005cited by this paper
• Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI

  2004cited by this paper
• PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.

  2004cited by this paper
• Multivalent Contrast Agents Based on Gadolinium-Diethylenetriaminepentaacetic Acid-Terminated Poly(propylene imine) Dendrimers for Magnetic Resonance Imaging

  2004cited by this paper
• Multivalent contrast agents based on Gd-DTPA-terminated poly (propylene imine) dendrimers for Magnetic Resonance Imaging

  2004cited by this paper
• Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.

  2003cited by this paper
• Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer

  2003cited by this paper
• Characteristics of a New MRI Contrast Agent Prepared From Polypropyleneimine Dendrimers, Generation 2

  2003cited by this paper
• Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates.

  2001cited by this paper
• Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.

  2001cited by this paper
• A new polysaccharide macromolecular contrast agent for MR imaging: Biodistribution and imaging characteristics

  2000cited by this paper
• Thiol-based antioxidants.

  2000cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

  1999cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999cited by this paper
• Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.

  1999cited by this paper
• Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.

  1998cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998cited by this paper
• High relaxivity linear Gd(DTPA)‐polymer conjugates: The role of hydrophobic interactions

  1997cited by this paper
• Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction.

  1995cited by this paper
• Detailed toxicity studies of liposomal gadolinium-DTPA.

  1991cited by this paper
• Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.

  1990cited by this paper
• The relationship between thermodynamics and the toxicity of gadolinium complexes.

  1990cited by this paper
• Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.

  1987cited by this paper
• Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies.

  1987cited by this paper
• Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.

  1987cited by this paper
• Gd(DOTA): An alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy

  1986cited by this paper
• Microvascular permeability of normal and neoplastic tissues.

  1986cited by this paper
• Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

  1984cited by this paper

• Solid phase synthesis in the development of magnetic resonance imaging probes

  2020cites this paper
• Chemical Functionalization of Nanodiamond for Nanobiomedicine

  2020cites this paper
• Recent advances in the polymerization of elemental sulphur, inverse vulcanization and methods to obtain functional Chalcogenide Hybrid Inorganic/Organic Polymers (CHIPs)

  2019cites this paper
• Recent advances on stimuli-responsive macromolecular magnetic resonance imaging (MRI) contrast agents

  2018cites this paper
• Metal Complexes with Polymer Chelating Ligands

  2018cites this paper
• Design Strategies of Metal Complexes Based on Chelating Polymer Ligands and Their Application in Nanomaterials Science

  2018cites this paper
• A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.

  2016cites this paper
• Dendrimer-Based Nanodevices as Contrast Agents for MR Imaging Applications

  2016cites this paper
• Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model

  2015cites this paper
• Synthesis, Characterization, and Magnetic Resonance Evaluation of Polyglycerol-Functionalized Detonation Nanodiamond Conjugated with Gadolinium(III) Complex.

  2015cites this paper
• Dendritic nanoglobules with polyhedral oligomeric silsesquioxane core and their biomedical applications.

  2014cites this paper
• Polymer-drug conjugates: origins, progress to date and future directions.

  2013cites this paper
• Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.

  2013cites this paper
• Gadolinium-based contrast agents for magnetic resonance cancer imaging.

  2013cites this paper
• Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.

  2013cites this paper
• La tomografía computarizada y la resonancia magnética en patologías frecuentes de órbita y vía óptica. Una revisión

  2013cites this paper
• Magnetic nanoparticle-based cancer nanodiagnostics

  2013cites this paper
• Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

  2012cites this paper
• Polydisulfide manganese(II) complexes as non‐gadolinium biodegradable macromolecular MRI contrast agents

  2012cites this paper
• Research Progress of Magnetic Resonance Imaging Contrast Agents

  2011cites this paper
• Polymer Therapeutics—From Bench to Bedside

  2010cites this paper